自身免疫性疾病(autoimmune diseases,AID)病情复杂、病程漫长,大多需要长期用药。传统治疗药物长期使用不仅有耐药倾向,且存在一定不良反应,临床迫切需要高效低毒的替代药物。本文对近20年国内青蒿素衍生物(artemisinin and its deriva...自身免疫性疾病(autoimmune diseases,AID)病情复杂、病程漫长,大多需要长期用药。传统治疗药物长期使用不仅有耐药倾向,且存在一定不良反应,临床迫切需要高效低毒的替代药物。本文对近20年国内青蒿素衍生物(artemisinin and its derivatives,ARTs)治疗自身免疫性疾病研究文献进行了知识图谱可视化分析。我国ARTs治疗AID相关领域初步形成少数研究团队,研究方式多为基础医学实验,研究内容聚焦在该类药物对类风湿关节炎(rheumatoid arthritis,RA)、系统性红斑狼疮(systemic lupus erythematosus,SLE)等疾病疗效作用机制方面。研究发现ARTs对AID发生发展过程中的多个环节均有干预作用,包括免疫细胞功能紊乱、炎症通路异常激活、组织细胞异常分化等。ARTs在治疗AID中展现出了强大的治疗潜力,有望成为治疗AID的新型药物。目前研究尚局限于机制探索、基础实验干预等,相关临床研究亟待开展以验证其有效性与安全性。展开更多
OBJECTIVE:To investigate the possible mechanism underlying the effect of the Lushi Runzao decoction(路氏润燥汤)on Sjogren's syndrome using network pharmacology and to verify the mechanisms via animal experiments.M...OBJECTIVE:To investigate the possible mechanism underlying the effect of the Lushi Runzao decoction(路氏润燥汤)on Sjogren's syndrome using network pharmacology and to verify the mechanisms via animal experiments.METHODS:Available biological data on each drug in the Lushi Runzao decoction were retrieved from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform,and the target proteins of Sjogren's syndrome were retrieved from the GeneCards database.Information regarding Sjogren's syndrome and the targets of the drugs were compared to obtain overlapping elements.This information was imported into the STRING platform to obtain a proteinprotein interaction network diagram,following which a“component-target”network diagram was constructed using screened drug components and target information via Cytoscape software.The database for annotation,visualization,and integrated discovery was used for Gene Ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathways analyses.Pathway information predicted by network pharmacology was verified using animal experiments.RESULTS:The Lushi Runzao decoction ameliorated Sjogren's syndrome mainly by influencing tumor necrosis factor as well as certain cytokines and chemokines.The decoction also influenced the interleukin-17 and advanced glycosylation end products(AGE)-receptor for AGE signaling pathways.CONCLUSION:The Lushi Runzao decoction ameliorates Sjogren's syndrome via multiple targets and multiple signaling pathways.Network pharmacology is useful for making a comprehensive prediction regarding the efficacy of the Lushi Runzao decoction,and this information may be helpful in clinical research.展开更多
文摘自身免疫性疾病(autoimmune diseases,AID)病情复杂、病程漫长,大多需要长期用药。传统治疗药物长期使用不仅有耐药倾向,且存在一定不良反应,临床迫切需要高效低毒的替代药物。本文对近20年国内青蒿素衍生物(artemisinin and its derivatives,ARTs)治疗自身免疫性疾病研究文献进行了知识图谱可视化分析。我国ARTs治疗AID相关领域初步形成少数研究团队,研究方式多为基础医学实验,研究内容聚焦在该类药物对类风湿关节炎(rheumatoid arthritis,RA)、系统性红斑狼疮(systemic lupus erythematosus,SLE)等疾病疗效作用机制方面。研究发现ARTs对AID发生发展过程中的多个环节均有干预作用,包括免疫细胞功能紊乱、炎症通路异常激活、组织细胞异常分化等。ARTs在治疗AID中展现出了强大的治疗潜力,有望成为治疗AID的新型药物。目前研究尚局限于机制探索、基础实验干预等,相关临床研究亟待开展以验证其有效性与安全性。
基金the National Natural Science Foundation of China:Based on the Intestinal flora/SCFAs/FFA2 Approach to Explore the Mechanism of Lushi Runzao Decoction in Regulating Th17/Treg Immune Balance to treat Sjogren's Syndrome(No.82104837)。
文摘OBJECTIVE:To investigate the possible mechanism underlying the effect of the Lushi Runzao decoction(路氏润燥汤)on Sjogren's syndrome using network pharmacology and to verify the mechanisms via animal experiments.METHODS:Available biological data on each drug in the Lushi Runzao decoction were retrieved from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform,and the target proteins of Sjogren's syndrome were retrieved from the GeneCards database.Information regarding Sjogren's syndrome and the targets of the drugs were compared to obtain overlapping elements.This information was imported into the STRING platform to obtain a proteinprotein interaction network diagram,following which a“component-target”network diagram was constructed using screened drug components and target information via Cytoscape software.The database for annotation,visualization,and integrated discovery was used for Gene Ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathways analyses.Pathway information predicted by network pharmacology was verified using animal experiments.RESULTS:The Lushi Runzao decoction ameliorated Sjogren's syndrome mainly by influencing tumor necrosis factor as well as certain cytokines and chemokines.The decoction also influenced the interleukin-17 and advanced glycosylation end products(AGE)-receptor for AGE signaling pathways.CONCLUSION:The Lushi Runzao decoction ameliorates Sjogren's syndrome via multiple targets and multiple signaling pathways.Network pharmacology is useful for making a comprehensive prediction regarding the efficacy of the Lushi Runzao decoction,and this information may be helpful in clinical research.
